Goudarzi Z, Lotfi F, Najafpour Z, Hafezi A, et al. Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran. BMC Urol 2024;24:45.
PMID: 38378521